G1 Therapeutics (GTHX) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 41.18%. A quarter ago, it was expected that this company would post a loss of $0.19 per share when it actually produced a loss of $0.20, delivering a surprise of -5.26%. Over the last four quarters, the company has su ...